ArticleFrontiers in immunology2022

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.

Rui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.